MedTrace Logo

The Therapeutic Effect of Expressive Writing.

NCT07567157 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-05

No results posted yet for this study

Summary

The goal of this clinical trial is to understand the impact of compassionate expressive writing in people living with and beyond cancer. The main question it aims to answer is:

Does compassionate expressive writing have any impact on well-being outcomes in people living with and beyond cancer, such as body compassion, self-compassion, quality of life and psychological well-being outcomes ?

Researchers will compare compassionate expressive writing with a standard expressive writing task (with no compassionate prompt) to see if there is a difference in self-reported body compassion, self-compassion, quality of life and psychological well-being outcomes between the two conditions.

Participants will :

Complete a series of pre-intervention questionnaires. Be assigned to one of the two writing conditions. Attend four expressive writing sessions and write freely for approximately 20 minutes in response to a topic related to their cancer experience.

Complete a series of post-intervention questionnaires. Repeat the questionnaires at 1-month follow-up.

Conditions

Interventions

BEHAVIORAL

Compassionate Expressive Writing

A 20-minute practitioner-led expressive writing session that involves the practitioner introducing a topic related to cancer such as, the impact of diagnosis/treatment on relationships with others, with ones body, with the world. Participants are encouraged to write freely and are prompted to remain compassionate towards themselves and their experience at the start of the writing session.

BEHAVIORAL

Standard Expressive Writing

A 20-minute practitioner-led expressive writing session that involves the practitioner introducing a topic related to cancer such as, the impact of diagnosis/treatment on relationships with others, with ones body, with the world. Participants are not prompted to think compassionately in this condition but allowed to write freely about the topic without further structure.

Sponsors & Collaborators

  • University of Plymouth

    collaborator OTHER

  • Royal Cornwall Hospitals Trust

    lead OTHER

Principal Investigators

  • Ariane Scalpello · Royal Cornwall Hospital NHS Trust, University of Plymouth

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-22
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07567157 on ClinicalTrials.gov